我院2018—2022年补益类中成药的应用分析  

Application Analysis of Tonic Chinese Patent Drugs in Our Hospital from 2018 to 2022

作　　者：苏利红[1] 马丽娟[1] 黑晶 SU Lihong;MA Lijuan;HEI Jing(Pharmacy Department,General Hospital of Ningxia Medical University,Yinchuan,Ningxia 750004)

机构地区：[1]宁夏医科大学总医院药剂科,宁夏银川750004

出　　处：《智慧健康》2024年第5期17-20,共4页Smart Healthcare

摘　　要：目的 分析2018年1月—2022年12月我院补益类中成药的应用现状及趋势,为此类药的合理使用提供参考。方法 统计2018年1月—2022年12月药品数据库中补益类中成药年销售金额和用量进行统计,分析补益类中成药的销售金额、用药频度(DDDs)、日用药金额(DDC)、总金额排序号/DDDs排序号(DUI)值。结果 补益类中药口服剂型用药金额呈逐年上升趋势,注射剂构成比呈逐年下降趋势。口服剂型得到越来越广泛的应用,但是价格偏高。结论 我院补益药中成药品种结构基本合理,常用的补益药DDC值偏高,患者经济负担过重。补益药的不良反应发生率逐年增加,应注重合理用药。Objective To analyze current situation and application trend of tonic Chinese patent drugs in our hospital from January 2018 to December 2022,and provide reference for rational use of such drugs.Methods The paper counted annual sales amount and consumption of tonic Chinese patent drugs in the drug database from January 2018 to December 2022,and analyzed sales amount,defined daily doses(DDDs),daily drug cost(DDC),total amount ranking number/DDDs ranking number(DUI)of tonic Chinese patent drugs with DDDs analysis method.Results Daily drug cost of oral forms of tonic Chinese patent drugs has been increasing year by year,while proportion of injections has been decreasing year by year.Oral dosage forms have been widely applied,but they are relatively expensive.Conclusion Variety structure of tonic Chinese patent drugs in our hospital is basically reasonable,the value of commonly used tonic drugs is on the high side,and economic burden of patients is too heavy.Incidence of adverse reactions of tonifying drugs has been increasing year by year,it is necessary to pay attention to rational drug use.

关 键 词：补益类中成药 用药分析 用药金额 用药频度 合理用药 

分 类 号：R288[医药卫生—中药学]